medRxiv PreprintsInternational19 November 2026
Promoter methylation of LDLR is not a common cause of familial hypercholesterolemia
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background/Objectives: Familial hypercholesterolemia (FH) is a widely prevalent inherited disorder defined by chronically high LDL-C concentrations and a significantly increased risk of cardiovascular disease. While FH is primarily an autosomal dominant disease caused by pathogenic mutations in LDLR, APOB, or PCSK9, approximately 20-60% of clinically diagnosed patients are mutation-negative. A previous survey of over 23,000 methylation profiles identified a differentially methylated region in the promoter of LDLR. This study aimed to investigate whether constitutional hypermethylation of the L
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.